Entera Bio Ltd
NASDAQ:ENTX
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
E
|
Enplas Corp
TSE:6961
|
JP |
|
E
|
ENEOS Holdings Inc
SWB:JHJ
|
JP |
|
N
|
Nordic Iron Ore AB
STO:NIO
|
SE |
|
360 Security Technology Inc
SSE:601360
|
CN |
|
SEC Electric Machinery Co Ltd
SSE:603988
|
CN |
|
Nishi-Nippon Railroad Co Ltd
TSE:9031
|
JP |
|
Biome Technologies PLC
LSE:BIOM
|
UK |
|
Victoria PLC
LSE:VCP
|
UK |
|
KLab Inc
TSE:3656
|
JP |
|
Grupo Financiero Inbursa SAB de CV
BMV:GFINBURO
|
MX |
|
N
|
Nelly Group AB (publ)
STO:NELLY
|
SE |
|
G
|
Get Nice Financial Group Ltd
HKEX:1469
|
HK |
|
Shindengen Electric Manufacturing Co Ltd
TSE:6844
|
JP |
|
Catella AB
STO:CAT B
|
SE |
|
Hagoromo Foods Corp
TSE:2831
|
JP |
|
Honeys Holdings Co Ltd
TSE:2792
|
JP |
|
D
|
Dioo Microcircuits Co Ltd Jiangsu
SSE:688381
|
CN |
|
K
|
Kinjiro Co Ltd
TSE:4013
|
JP |
|
S.F. Holding Co Ltd
SZSE:002352
|
CN |
|
Beauty Garage Inc
TSE:3180
|
JP |
|
Huanlejia Food Group Co Ltd
SZSE:300997
|
CN |
|
Hyundai Pharmaceutical Co Ltd
KRX:004310
|
KR |
|
C
|
CI Holdings Bhd
KLSE:CIHLDG
|
MY |
|
Globalspace Technologies Ltd
BSE:540654
|
IN |
Entera Bio Ltd
EPS (Diluted)
Entera Bio Ltd
EPS (Diluted) Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | EPS (Diluted) | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Entera Bio Ltd
NASDAQ:ENTX
|
EPS (Diluted)
$0
|
CAGR 3-Years
-12%
|
CAGR 5-Years
17%
|
CAGR 10-Years
N/A
|
|
|
Kamada Ltd
NASDAQ:KMDA
|
EPS (Diluted)
$0
|
CAGR 3-Years
N/A
|
CAGR 5-Years
-2%
|
CAGR 10-Years
N/A
|
|
|
Enlivex Therapeutics Ltd
NASDAQ:ENLV
|
EPS (Diluted)
$0
|
CAGR 3-Years
29%
|
CAGR 5-Years
4%
|
CAGR 10-Years
35%
|
|
|
Urogen Pharma Ltd
NASDAQ:URGN
|
EPS (Diluted)
-$3
|
CAGR 3-Years
13%
|
CAGR 5-Years
12%
|
CAGR 10-Years
N/A
|
|
|
Pluri Inc
NASDAQ:PLUR
|
EPS (Diluted)
-$2
|
CAGR 3-Years
29%
|
CAGR 5-Years
24%
|
CAGR 10-Years
19%
|
|
|
M
|
Matricelf Ltd
TASE:MTLF
|
EPS (Diluted)
₪0
|
CAGR 3-Years
10%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Entera Bio Ltd
Glance View
Entera Bio Ltd. is a clinical-stage biopharmaceutical company, which focuses on the development and commercialization of orally delivered large molecule therapeutics. The firm conducts clinical trials on its proprietary technology, which allows oral delivery of large molecules and biologics while enhancing their absorption in the gastrointestinal (GI) tract. Entera Bio Ltd's technology addresses the major problems of oral drug delivery of large molecule active pharmaceutical ingredients (APIs). Most large molecules cannot be administered orally as they are not readily absorbed by the gastrointestinal tract and are rapidly degraded by a myriad of enzymes and acids in the gastrointestinal tract. The Company’s proprietary technologies act synergistically to transport and protect large molecules. The firm develops drugs for hypoparathyroidism, osteoporosis and bone healing.
See Also
What is Entera Bio Ltd's EPS (Diluted)?
EPS (Diluted)
-0.2
USD
Based on the financial report for Sep 30, 2025, Entera Bio Ltd's EPS (Diluted) amounts to -0.2 USD.
What is Entera Bio Ltd's EPS (Diluted) growth rate?
EPS (Diluted) CAGR 5Y
17%
Over the last year, the EPS (Diluted) growth was -14%. The average annual EPS (Diluted) growth rates for Entera Bio Ltd have been -12% over the past three years , 17% over the past five years .
